| Literature DB >> 34954282 |
Murilo Rezende Oliveira1, Isabella Pessóta Sudati2, Vanessa De Mello Konzen3, Ana Carolina de Campos2, Lia Mara Wibelinger3, Clisman Correa4, Fabiano Moraes Miguel4, Rebeca Nunes Silva2, Audrey Borghi-Silva2.
Abstract
INTRODUCTION: Social isolation and lifestyle changes provoked by the COVID-19 pandemic have negatively affected the level of physical activity of the elderly people.Entities:
Keywords: COVID-19; Elderly people; Physical activity; Physical exercise
Mesh:
Year: 2021 PMID: 34954282 PMCID: PMC8695515 DOI: 10.1016/j.exger.2021.111675
Source DB: PubMed Journal: Exp Gerontol ISSN: 0531-5565 Impact factor: 4.032
Fig. 1Study flowchart.
Sample characteristics and sociodemographic data.
| Author (Year) | Study design | Country | Sample size (n) | Male (%) | Age (years) | Main comorbidities |
|---|---|---|---|---|---|---|
| Cross-Sectional | Italy | 296 | NM | Over 60 | NM | |
| Cross-Sectional | Japan | 999 | 462 (46) | 74.5 ± 6.3 | NM | |
| Cohort | The Netherlands | 1119 | 528 (47.2) | 74 ± 7.0 | NM | |
| Cohort | Korea | 100 | 54 (54) | 70 (62.3–76.0) | PD | |
| Cross-Sectional | Turkish | 88 | 54 (61) | PD: 67 (60.0–73.5); | PD | |
| Cross-Sectional | Spain | 98 | 33 (34) | 82.4 ± 6.1 | NM | |
| Cohort | Brazil | 35 | 12 (34.3) | 65.6 ± 3.8 | HT; Db; Dl; Ow; Ob. | |
| Cross-Sectional | USA | 1062 | NM | ≥65 | NM | |
| Cross-Sectional | UK | 117 | 52 (44.4) | 75 ± 4 | NM | |
| Cross-Sectional | Italy | 126 | 24 (19) | 74.29 ± 6.51 | Ob; Db; Ht; Hl; CVd; Mskd; Thd; Aid; Respd. | |
| Cohort | China | 621 | 383 (16.5) | ≥60 | NM | |
| Cohort | Japan | 165 | 50 (30.7) | 78.6 ± 8.0 | Ht; Hl; Db; CVd; Mskd; Thd; Aid; Respd. | |
| Cohort | Spain | 37 | NM | 68.2 | Db | |
| Cross-sectional | China | 184 | 93 (50.54) | ≥60 | NM | |
| Cross-sectional | Japan | 1600 | 800 (50) | 74 ± 5.6 | NM | |
| Cross-sectional | Brazil | 47 | 32 (69) | 66.3 ± 5.07 | NM | |
| Cross-sectional | France | 1178 | 568 (48.2) | 69.7 ± 4.2 | NM | |
| Cohort | Japan | 13 | 2 (15,4) | 77,5 ± 3,5 | Ht; D1 | |
| Cohort | Japan | 937 | 479 (51.1) | 73.5 | NM | |
| Cross-sectional | Portugal | 68 | 40 (59) | 74.24 | NM | |
| Cross-sectional | Brazil | 1123 | 101 (9) | 67.6 | Dp | |
| Cohort | Brazil | 72 | 13 (18) | 67.2 | NM | |
| Cohort | Spain | 829 | 330 (39.8) | 81.5 | NM | |
| Cross-sectional | Sweden | 89 | 48 (54) | 71 | PD | |
| Cohort | UK | 4961 | 2208 (44.5) | >65 | NM |
Legend: Not mentioned (NM); United Kingdom (UK); Hypertension (Ht); Diabetes (Db); Parkinson's disease (PD); Dyslipidemia (Dl); Overweight (Ow); Obesity (Ob); United States of America (USA); Hyperlipidemia (Hl); Cardiovascular Diseases (CVd); Musculoskeletal Disorder (Mskd); Thyroid Dysfunction (Thd); Autoimmune Disease (Aid); Pré-existing respiratory illness (Respd); Depression (Dp).
When the sample was mixed, only the population ≥60 years was considered.
When the sample was mixed, only the population of validated assessment was considered.
PA level during the COVID-19 pandemic.
| Author (Year) | Activity level assessment method | Cut-off points for PA level | Main outcomes |
|---|---|---|---|
| IPAQ-SF. | - Low active (<600 MET–minutes/week); | - Statistically significant difference between before and during COVID-19 pandemic (Mean: 2429 vs. 1577 MET–min/wk.; | |
| IPAQ-SF. | - Walking (3.3 METs) | - PA was reduced by approximately 5–10% for moderate-intensity activity, walking, and total PA. After the restrictions, there was an increase in sitting time (5% increase for men,10% increase for women). | |
| LAPAQ. | - <150 versus ≥150 min/week | - Negative impact on PA behaviors (48.3–54.3% of the sample); | |
| PASE. | NM | - Significant decrease in the amount of exercise (duration and frequency and number of patients who do not exercise at all increased). | |
| PASE. | - Higher scores indicate greater physical activity. | - PA level was reduced in healthy and PD groups. | |
| BPAAT. | - Insufficiently active (score 0–3 points); | - A general decrease in PA level during the lockdown (BPAAT total score: −1.1/8 (95 CI% 0.6; 1.5) points; | |
| Accelerometer. | - Sedentary behavior (≤0 99 cpm); | - Increase in sedentary behavior ( | |
| IPAQ-SF. | - Inactive (0 min); | - 42.6% reported sitting for more than 8 h per day; | |
| IPAQ-E; LLFDI. | - High, moderate, or low PA (according to IPAQ-SV scoring protocol - | - Both males and females maintained their PA levels but also increased their sedentary time. | |
| IPAQ-SF. | - 600 MET/week roughly corresponding to 150 min of moderate intensity activity; | - 46 participants declared having decreased their PA; | |
| Daily step counts collected through a smartphone linked to a social network platform (WeChat). | - Low daily step (≤1500 steps/day) | - Daily steps dropped rapidly (by 2678 steps) and substantially and was more pronounced among females. | |
| PAQ-EJ | - Light housework (2.0 METs) | - 47.3% of the participants were less active and decreased their PA per week. | |
| IPAQ | - Moderate-intensity activities (>3 and <6 METs); | - Increase in sitting without doing any PA; | |
| IPAQ | - High, moderate, or low PA (according to IPAQ-SV scoring protocol - | - 41.3% of insufficient PA was found during home quarantine induced by COVID-19. | |
| IPAQ | - Moderate-intensity activities (>3 and <6 METs); | - Significant decrease in total PA time in April 2020 (median [IQR], 180 [0 to 420]) when compared to January 2020 (median [IQR], 245 [90 to 480]) ( | |
| IPAQ | - Inactive - <600 MET-min/week; | - In the pandemic period, 84% of the sample was considered inactive, 13% moderate active, and 3% high active; | |
| IPAQ; ONAPS-PAQ | - Inactive (≤ 2 h and 30 min per week of moderate to vigorous PA). | - 39.2% decreased PA during the confinement; | |
| Accelerometer | - Light-intensity PA (1.5–2.9 METs); | - The PA level of daily activity decreased by 32.6%; | |
| IPAQ-SF. | - Moderate-intensity activities (>3 and <6 METs); | - Significant decrease in total PA time in April 2020, August 2020 and January 2021 than in January 2020 (P < 0.001). | |
| IPAQ-SF. | - High, moderate, or low PA (according to IPAQ-SV scoring protocol - | - 90% of older adults self-reported a decrease in overall PA levels; | |
| IPAQ-SF | - <150 min per week" or “>150 min per week” of moderate to vigorous PA. | - 83.80% self-reported a decrease in daily PA levels ( | |
| IPAQ-SF | - Low PA level (0 to <600 MET·min weekly); | - At the beginning of the study, 56.8% of the older adults were classified as active, and after the first month, 18.5% reported changes in this condition; | |
| PASE | NM | - Mean reduction in the PASE score of 16.66 points | |
| Accelerometer | - Sedentary behavior (<100 counts per minute) | - No statistically significant difference in overall PA level (steps per day) was seen between prepandemic and postpandemic measures ( | |
| IPAQ-SF | - Low active (<600 MET–minutes/week); | - Mean PA was significantly lower following the introduction of lockdown from 3519 to 3185 MET min/week (p < 0.001) |
Legend: Physical Activity (PA); International Physical Activity Questionnaire-Short form (IPAQ-SF); Longitudinal Aging Study Amsterdam Physical Activity Questionnaire (LAPAQ); Parkinson's disease (PD); Physical Activity Scale for the Elderly (PASE); Brief Physical Activity Assessment Tool (BPAAT); Late-Life Function and Disability Instrument (LLFDI); Metabolic Equivalent Task (MET); International Physical Activity Questionnaire Environment Module (IPAQ-E); Physical Activity Questionnaire for Elderly Japanese (PQA-EJ); Body Mass Index (BMI); World Health Organization (WHO); Not mentioned (NM); Interquartile range (IQR).
Quality assessments for cross-sectional studies included (NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE).
| Cross-sectional studies | Selection | Comparability | Outcome | Total Score | ||||
|---|---|---|---|---|---|---|---|---|
| Representativeness of the sample | Sample size | Non-respondents | Ascertainment of the exposure (risk factor) | The subjects in different outcome groups are comparable | Assessment of the outcome | Statistical test | ||
| – | – | ☆ | ☆☆ | ☆☆ | ☆ | ☆ | ☆☆☆☆☆☆☆ (7) | |
| – | ☆ | ☆ | ☆☆ | ☆ | ☆ | ☆ | ☆☆☆☆☆☆☆ (7) | |
| – | – | – | – | – | ☆ | ☆ | ☆☆ (2) | |
| ☆ | ☆ | – | ☆☆ | – | ☆ | ☆ | ☆☆☆☆☆☆ (6) | |
| – | ☆ | – | ☆☆ | ☆ | ☆ | ☆ | ☆☆☆☆☆☆ (6) | |
| – | ☆ | – | ☆☆ | ☆ | ☆ | ☆ | ☆☆☆☆☆☆ (6) | |
| – | – | – | ☆ | ☆☆ | ☆ | ☆ | ☆☆☆☆☆ (5) | |
| – | ☆ | ☆ | ☆☆ | – | ☆ | – | ☆☆☆☆☆☆ (6) | |
| – | ☆ | ☆ | ☆☆ | ☆ | ☆ | ☆ | ☆☆☆☆☆☆☆ (7) | |
| – | ☆ | ☆ | ☆☆ | ☆ | ☆ | ☆ | ☆☆☆☆☆☆☆ (7) | |
| – | – | ☆ | ☆☆ | ☆ | ☆ | ☆ | ☆☆☆☆☆☆ (6) | |
| – | – | – | ☆☆ | ☆ | ☆ | ☆ | ☆☆☆☆☆ (5) | |
| ☆ | ☆ | – | ☆☆ | ☆ | ☆ | ☆ | ☆☆☆☆☆ ☆☆ (7) | |
| – | – | – | ☆☆ | ☆ | ☆ | ☆ | ☆☆☆☆☆ (5) | |
Quality assessments for cohort studies included (NEWCASTLE-OTTAWA QUALITY ASSESSMENT SCALE).
| Cohort studies | Selection | Comparability | Outcome | Total Score | |||||
|---|---|---|---|---|---|---|---|---|---|
| Representativeness of the exposed cohort | Selection of the non-exposed cohort | Ascertainment of exposure | Demonstration that outcome of interest was not present at start of study | Comparability of cohorts on the basis of the design or analysis | Assessment of outcome | Was follow-up long enough for outcomes to occur | Adequacy of follow up of cohorts | ||
| – | – | ☆ | ☆ | ☆ | – | ☆ | ☆ | ☆☆☆☆☆ (5) | |
| – | – | – | – | ☆ | – | ☆ | ☆ | ☆☆☆ (3) | |
| – | – | ☆ | ☆ | – | ☆ | ☆ | ☆ | ☆☆☆☆☆ (5) | |
| ☆ | – | – | ☆ | ☆ | – | – | ☆ | ☆☆☆☆ (4) | |
| – | – | – | ☆ | ☆☆ | – | – | ☆ | ☆☆☆☆ (4) | |
| ☆ | – | – | – | ☆ | ☆ | – | ☆ | ☆☆☆☆ (4) | |
| – | – | – | ☆ | ☆☆ | – | ☆ | ☆ | ☆☆☆☆☆ (5) | |
| ☆ | – | – | ☆ | ☆ | – | ☆ | ☆ | ☆☆☆☆☆ (5) | |
| – | – | – | ☆ | ☆ | – | ☆ | ☆ | ☆☆☆☆ (4) | |
| ☆ | – | – | ☆ | ☆ | – | ☆ | ☆ | ☆☆☆☆☆ (5) | |
| ☆ | – | – | ☆ | ☆ | – | ☆ | ☆ | ☆☆☆☆☆ (5) | |